People
Pyrrolobenzodiazepine-based antibody drug conjugates demonstrate potential for the treatment of relapsed or refractory lymphomas as single agents and in combination therapies
Seasoned business executive will bring important insights in licensing strategy and contribute to Domain’s next phase of development
The round brings total financing up to $95 million.
The indictment revolves around several investment projects including the development of a biotech company, AnC Bio Vermont, in Newport, Vermont, and the government’s EB-5 program, which offers permanent U.S. residency in exchange for $500,000 investments in approved businesses that will create specific numbers of jobs.
Vygon Asia announces that it has donated 50 Vygon Polysite ISP implantable ports for patients undergoing chemotherapy at the Mount Miriam Cancer Hospital under the One Port One Life program.
Denis Rebrikov indicates he plans to ask for approval from three government agencies, including Russia’s health ministry. He told Nature that could take anywhere from one month to two years.
“HealthCaring Conversations is a blueprint for having an efficient but empathic conversation with a patient,” said Suzann Johnson, Janssen’s associate director of clinical insights and experience. “We’re taking good conversations and making them great by putting the patient at the center of every conversation.”
There has been a spate of recent news regarding the expansion of facilities and the expected job growth for the biopharma and life sciences industry. Here’s a look at some of those stories.
Brandicourt, who has helmed Sanofi since 2015, will retire from his CEO role this fall. Sanofi has a rule that its CEO cannot be over the age of 65.
The guidance tends to focus on getting sponsor companies to include more historically underserved populations in clinical trials, including women, the elderly and minorities.
PRESS RELEASES